Day: February 25, 2025

Official NoticeETP: 21Shares Bitcoin ETP ISIN: CH0454664001 TIDM: ABTC / BTCUETP: 21Shares Ethereum Staking ETP ISIN: CH0454664027 TIDM: AETH / ETHUETP: 21Shares Bitcoin Core ETP ISIN: CH1199067674 TIDM: CBTC / CBTU ETP: 21Shares Ethereum Core Staking ETP ISIN: CH1209763130 TIDM: ETHC/ CETU(hereinafter referred to as the “Products”)Name, registered office and address of the Company: 21Shares AG is a stock corporation under the laws of Switzerland. It has its registered office and address at Pelikanstrasse 37, 8001 Zurich.Technical corrections to earlier releases as for the TranchesThe Company has updated its Final Terms, specifically concerning sections “(iii) Tranche” and “(v) Aggregate Number of Products Represented by This Tranche.” Since 24 May 2024, the Company has been considering all shares of the Products issued...

WILMINGTON, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) — Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FSE: E30) a leading technology provider of AI-based next generation detection solutions for concealed weapons and threats, is pleased to announce that Jason Burinescu has been named as Liberty Defense’s new Executive Chairman of the Board, effective immediately. Daryl Rebeck is stepping down as Executive Chairman after serving in that capacity for the past four years. Mr. Burinescu is a Managing Partner of Vision Equity Partner Solutions, an investment and advisory firm (“Vision”). Before Vision, Jason led business development and served as a senior member of the investment team at Fletch Equity, a Los Angeles based private equity firm that has completed more than $1 billion in total transaction...

Company Expects to Begin Commercial Rollout, Converting Beta Users, Adding New Partners and Expanding Access to Early Registrations VANCOUVER, British Columbia, Feb. 25, 2025 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) (“VERSES” or the “Company”) a cognitive computing company specializing in next-generation intelligent software systems, announces that the Company expects to launch the commercial version of Genius in April. Genius is a suite of tools for designing autonomous intelligent agents that continuously reason, plan and learn. “The private beta phase of Genius allowed us to validate its applicability across diverse use cases, including autonomous vehicle safety, fleet optimization, fraud detection, credit risk assessment, financial market modeling, and medication efficacy. These real-world...

Lenexa, KS, Feb. 25, 2025 (GLOBE NEWSWIRE) — Digital Ally, Inc. (NASDAQ: DGLY)(the “Company” or “Digital Ally”), a leading provider of video solutions that develops, manufactures, and markets advanced video recording products and other critical safety products for law enforcement, emergency management, fleet safety, and event security, is forging ahead with cutting-edge innovations and strong leadership aimed at reshaping the future of security and efficiency in video technology systems. The Company today announced that it has been granted six new patents by the United States Patent and Trademark Office (USPTO) over the past 12 months. These patents span multiple industries, products, and technologies, reinforcing Digital Ally’s leadership in video technology and safety solutions. Covering applications from law enforcement to commercial...

SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) today announced that Eli Lilly and Company (NYSE:LLY) (“Lilly”) will acquire Organovo’s FXR program, including its lead asset, FXR314. “This is a significant milestone for our efforts to advance medicines for IBD using insights from our proprietary 3D human tissue models,” said Keith Murphy, Executive Chairman. “We are excited to deliver FXR314 and our FXR program to Lilly for Phase 2 and further development. Their world-class development excellence and dedication to delivering for patients will provide an excellent pathway for FXR314 success, and we are pleased to have this opportunity to deliver...

TERN-701 CARDINAL study progressing well; dose expansion expected to initiate in 2Q25 with additional safety and efficacy data in 4Q25 New TERN-701 data from ongoing U.S. healthy volunteer PK study shows improved drug-drug interaction profile compared to asciminib Introduces TERN-601 Phase 2 FALCON obesity study design; on track to initiate study in early 2Q25 with 12-week data expected 2H25 Cash and cash equivalents expected to provide runway into 2028 FOSTER CITY, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced that management will participate in the TD Cowen 45th Annual Healthcare Conference...

NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2024 after the close of the U.S. financial markets on March 10, 2025 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast DetailsDate: Monday, March 10thTime: 4:30 p.m. Eastern timeToll-Free Dial-In: 800-225-9448International Dial-In: 203-518-9708Conference ID: LIFEMDLive & Archived Webcast: Link   About LifeMD, Inc.LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s...

Domino’s uses hybrid cloud to expand its store network, scale operations during peak demand, and deliver a majority of its orders through digital channels SAN ANTONIO, Feb. 25, 2025 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a leading provider of hybrid and AI technology solutions, today announced working with Domino’s Pizza UK & Ireland Ltd. to enhance Domino’s digital capabilities to support the company’s growing store network through a robust hybrid cloud environment. Domino’s Pizza UK & Ireland Ltd., the region’s leading pizza delivery company, has redefined convenience and technology in the food delivery industry. As the master franchisee for the region, the company has transformed from a traditional takeaway business into a technology-driven enterprise, with most...

Thermoplastic nanocomposites promise enhanced performance for the construction industry and beyond BOCA RATON, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) — Xeriant, Inc. (OTCQB: XERI) (“Xeriant” or “the Company”), dedicated to the discovery, development, and commercialization of disruptive technologies in advanced materials and aerospace, is pleased to announce significant progress toward completing the development and certification of its eco-friendly NEXBOARD™ construction panels by enhancing its mechanical and thermal properties through the incorporation of nanotechnology. “At Xeriant, we are integrating nanotechnology to produce a nanocomposite called NEXBOARD, the next generation of building materials. By embedding engineered nanoparticles, we have created a product that will be lighter and stronger...

ST. LOUIS, Feb. 25, 2025 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in TD Cowen’s 45th Annual Healthcare Conference in Boston, Massachusetts. Mr. Fischel will present an overview of Stereotaxis on Monday, March 3rd, 2025, at 3:10 pm ET and will be available for one-on-one meetings that same day. “We appreciate the opportunity to participate in the TD Cowen Healthcare Conference and look forward to sharing our progress and strategy,” says Mr. Fischel. About StereotaxisStereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of...